Gudrun Hörnquist
Directeur/Bestuurslid bij Rare Thyroid Therapeutics International AB
Actieve functies van Gudrun Hörnquist
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Directeur/Bestuurslid | - | - |
Loopbaan van Gudrun Hörnquist
Eerdere bekende functies van Gudrun Hörnquist
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Algemeen Adviseur | 30-10-2009 | 03-06-2010 |
Statistieken
Internationaal
Zweden | 3 |
Operationeel
General Counsel | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Health Technology |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Health Technology |
- Beurs
- Insiders
- Gudrun Hörnquist
- Ervaring